>
Laboratory Of America Holdings logo

LH - Laboratory Of America Holdings Share Price

$254.75 2.7  1.1%

Last Trade - 09/04/21

Sector
Healthcare
Size
Large Cap
Market Cap Ā£18.14bn
Enterprise Value Ā£21.48bn
Revenue Ā£10.20bn
Position in Universe 493rd / 6827
Bullish
Bearish
Unlock LH Revenue
Momentum
Relative Strength (%)
1m +5.29%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -1.75%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
8,680 9,553 10,308 11,333 11,555 13,979 14,279 13,542 +10.0%
-16.7 +43.0 +1.0 +40.8 -6.5 +103.3 +9.70 -27.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,Laboratory Corp. of America Holdings revenues increased 21%to $13.98B. Net income increased 89% to $1.56B. Revenuesreflect LCD segment increase of 32% to $9.25B, CDD segmentincrease of 7% to $4.88B. Net income benefited from LCDsegment income increase from $1.09B to $2.63B. BasicEarnings per Share excluding Extraordinary Items increasedfrom $8.41 to $15.99.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for LH
Graphical History

Revenue

LH Revenue Unlock LH Revenue

Net Income

LH Net Income Unlock LH Revenue

Normalised EPS

LH Normalised EPS Unlock LH Revenue

PE Ratio Range

LH PE Ratio Range Unlock LH Revenue

Dividend Yield Range

LH Dividend Yield Range Unlock LH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
LH EPS Forecasts Unlock LH Revenue
Profile Summary

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated March 8, 1994
Public Since April 24, 1991
No. of Shareholders: 1,398
No. of Employees: 72,400
Sector Healthcare
Industry Healthcare Providers & Services
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 97,600,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LH
Upcoming Events for LH
Thursday 29th April, 2021
Q1 2021 Laboratory Corporation of America Holdings Earnings Call
Thursday 29th April, 2021
Q1 2021 Laboratory Corporation of America Holdings Earnings Release
Wednesday 12th May, 2021
Laboratory Corporation of America Holdings Annual Shareholders Meeting
Thursday 13th May, 2021 Estimate
Laboratory Corporation of America Holdings Annual Shareholders Meeting
Monday 26th July, 2021 Estimate
Q2 2021 Laboratory Corporation of America Holdings Earnings Release
Frequently Asked Questions for Laboratory of America Holdings
What is the Laboratory of America Holdings share price?

As of 09/04/21, shares in Laboratory of America Holdings are trading at $254.75, giving the company a market capitalisation of Ā£18.14bn. This share price information is delayed by 15 minutes.

How has the Laboratory of America Holdings share price performed this year?

Shares in Laboratory of America Holdings are currently trading at $254.75 and the price has moved by 73.54% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Laboratory of America Holdings price has moved by 16.97% over the past year.

What are the analyst and broker recommendations for Laboratory of America Holdings?

Of the analysts with advisory recommendations for Laboratory of America Holdings, there are there are currently 6 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Laboratory of America Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Laboratory of America Holdings next release its financial results?

Laboratory of America Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Laboratory of America Holdings dividend yield?

Laboratory of America Holdings does not currently pay a dividend.

Does Laboratory of America Holdings pay a dividend?

Laboratory of America Holdings does not currently pay a dividend.

When does Laboratory of America Holdings next pay dividends?

Laboratory of America Holdings does not currently pay a dividend.

How do I buy Laboratory of America Holdings shares?

To buy shares in Laboratory of America Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopediaā€™s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Laboratory of America Holdings?

Shares in Laboratory of America Holdings are currently trading at $254.75, giving the company a market capitalisation of Ā£18.14bn.

Where are Laboratory of America Holdings shares listed? Where are Laboratory of America Holdings shares listed?

Here are the trading details for Laboratory of America Holdings:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: LH
What kind of share is Laboratory of America Holdings?

Based on an overall assessment of its quality, value and momentum, Laboratory of America Holdings is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Laboratory of America Holdings share price forecast 2021?

Shares in Laboratory of America Holdings are currently priced at $254.75. At that level they are trading at 5.93% discount to the analyst consensus target price of 0.00.

Analysts covering Laboratory of America Holdings currently have a consensus Earnings Per Share (EPS) forecast of 21.345 for the next financial year.

How can I tell whether the Laboratory of America Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Laboratory of America Holdings. Over the past six months, the relative strength of its shares against the market has been 12.25%. At the current price of $254.75, shares in Laboratory of America Holdings are trading at 23.52% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Laboratory of America Holdings PE Ratio?

The Laboratory of America Holdings PE ratio based on its reported earnings over the past 12 months is 13.09. The shares are currently trading at $254.75.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Laboratory of America Holdings?

Laboratory of America Holdings's management team is headed by:

Jean-Luc Belingard - IND
Kerrii Anderson - IND
Peter Neupert - LED
Adam Schechter - PRE
Glenn Eisenberg - CFO
D. Gary Gilliland - IND
Lance Berberian - EVP
Brian Caveney - EVP
Peter Wilkinson - SVP
Sandra Van Der Vaart - EVP
Paul Kirchgraber - EVP
Mark Schroeder - EVP
Jeffrey Davis - IND
Judith Seltz - CHO
Amy Summy - EVP
Who are the major shareholders of Laboratory of America Holdings?

Here are the top five shareholders of Laboratory of America Holdings based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 10.66% (10.4m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.91% (4.80m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.17% (4.07m shares)
Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 2.81% (2.74m shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 2.81% (2.75m shares)
Similar to LH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.